Stockreport

New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Trip...

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF FOSTER CITY, Calif., January 21, 2026 BUSINESS WIRE )--Gilead Sciences, Inc. (Nasdaq: GILD) today announced The New England Journal of Medicine NEJM ) published the ful [Read more]